NIVF vs PGNY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

NIVF

36.3
AI Score
VS
NIVF Wins

PGNY

31.8
AI Score

Investment Advisor Scores

NIVF

36score
Recommendation
SELL

PGNY

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NIVF PGNY Winner
Revenue 4.73M 1.29B PGNY
Net Income 9.88M 58.52M PGNY
Gross Margin 20.2% 23.6% PGNY
Net Margin 209.0% 4.5% NIVF
Operating Income -10.73M 85.28M PGNY
ROE 37.1% 11.3% NIVF
ROA 30.2% 7.9% NIVF
Total Assets 32.72M 742.43M PGNY
Cash 758,621 112.24M PGNY
Current Ratio 3.12 2.73 NIVF
Free Cash Flow -11.06M 191.78M PGNY

Relative Price Performance (Last 90 Days)

NIVF 1M: -7.5% · 3M: -62.0% PGNY 1M: +31.8% · 3M: +42.8%

Current Technical Phase

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.8 · Price: $0.23

PGNY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.7% over 20 days), RSI 79

RSI (14): 79.3 · Price: $36.18

Fundamentals Snapshot

Metric NIVF PGNY
Market Cap — —
Forward P/E 0.0 15.1
Trailing P/E — 33.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin -2.4% 0.1%
EPS -34064.71 1.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.